Finfer Simon, Bellomo Rinaldo, McEvoy Suzanne, Lo Sing Kai, Myburgh John, Neal Bruce, Norton Robyn
Australian and New Zealand Intensive Care Society Clinical Trials Group, Carlton, Vic 3053, Australia.
BMJ. 2006 Nov 18;333(7577):1044. doi: 10.1136/bmj.38985.398704.7C. Epub 2006 Oct 13.
To determine whether outcomes of resuscitation with albumin or saline in the intensive care unit depend on patients' baseline serum albumin concentration.
Analysis of data from a double blind, randomised controlled trial.
Intensive care units of 16 hospitals in Australia and New Zealand.
6045 participants in the saline versus albumin fluid evaluation (SAFE) study.
Fluid resuscitation with 4% albumin or saline in patients with a baseline serum albumin concentration of 25 g/l or less or more than 25 g/l.
Primary outcome was all cause mortality at 28 days. Secondary outcomes were length of stay in the intensive care unit, length of stay in hospital, duration of renal replacement therapy, and duration of mechanical ventilation.
The odds ratios for death for albumin compared with saline for patients with a baseline serum albumin concentration of 25 g/l or less and more than 25 g/l were 0.87 and 1.09, respectively (ratio of odds ratios 0.80, 95% confidence interval 0.63 to 1.02); P=0.08 for heterogeneity. No significant interaction was found between baseline serum albumin concentration as a continuous variable and the effect of albumin and saline on mortality. No consistent interaction was found between baseline serum albumin concentration and treatment effects on length of stay in the intensive care unit, length of hospital stay, duration of renal replacement therapy, or duration of mechanical ventilation.
The outcomes of resuscitation with albumin and saline are similar irrespective of patients' baseline serum albumin concentration.
ISRCTN76588266.
确定在重症监护病房使用白蛋白或生理盐水进行复苏的结果是否取决于患者的基线血清白蛋白浓度。
对一项双盲随机对照试验的数据进行分析。
澳大利亚和新西兰16家医院的重症监护病房。
盐水与白蛋白液体评估(SAFE)研究中的6045名参与者。
对基线血清白蛋白浓度为25g/L及以下或高于25g/L的患者,分别用4%白蛋白或生理盐水进行液体复苏。
主要结局为28天的全因死亡率。次要结局包括在重症监护病房的住院时间、住院总时长、肾脏替代治疗时间以及机械通气时间。
基线血清白蛋白浓度为25g/L及以下和高于25g/L的患者,使用白蛋白与生理盐水相比的死亡比值比分别为0.87和1.09(比值比之比为0.80,95%置信区间为0.63至1.02);异质性检验P = 0.08。未发现基线血清白蛋白浓度作为连续变量与白蛋白和生理盐水对死亡率的影响之间存在显著交互作用。在基线血清白蛋白浓度与对重症监护病房住院时间、住院总时长、肾脏替代治疗时间或机械通气时间的治疗效果之间,未发现一致的交互作用。
无论患者的基线血清白蛋白浓度如何,使用白蛋白和生理盐水进行复苏的结果相似。
ISRCTN76588266。